7Baggers
 Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results  The News Journal Mon, 17 Nov 2025 00:19:38 GMT
 xenetic biosciences, inc. reports third quarter 2025 financial results  Knoxville News Sentinel Sun, 16 Nov 2025 18:12:39 GMT
 Xenetic Biosciences Reports Q3 2025 Financial Results  TipRanks Fri, 14 Nov 2025 04:44:30 GMT
 XBIO Reports Increase in Q3 Revenue and Strengthens Oncology Pro  GuruFocus Thu, 13 Nov 2025 14:32:23 GMT
 Xenetic Biosciences Q3 revenue up 67.2% on royalty gains  MarketScreener Thu, 13 Nov 2025 14:26:06 GMT
 xenetic reports q3 eps (33c) vs. (28c) last year  TipRanks Thu, 13 Nov 2025 14:00:47 GMT
 Xenetic Biosciences, Inc. Reports Third Quarter 2025 Financial Results  The Providence Journal Thu, 13 Nov 2025 13:41:15 GMT
 Xenetic Biosciences: Q3 Earnings Snapshot  CT Insider Thu, 13 Nov 2025 10:54:34 GMT
 published on: 2025-11-13 00:09:09  newser.com Thu, 13 Nov 2025 06:09:09 GMT
 xenetic biosciences closes $4.5 million public offering of common stock  Global Legal Chronicle Thu, 13 Nov 2025 00:00:00 GMT
 Xenetic Biosciences: Q3 Earnings Snapshot  Greenwich Time Wed, 12 Nov 2025 08:00:00 GMT
 published on: 2025-11-09 05:50:38  newser.com Sun, 09 Nov 2025 11:50:38 GMT
 Xenetic Biosciences (XBIO) Projected to Post Earnings on Tuesday  Defense World Sun, 09 Nov 2025 08:01:07 GMT
 published on: 2025-11-04 01:29:19  newser.com Tue, 04 Nov 2025 07:29:19 GMT
 published on: 2025-10-31 03:41:46  newser.com Fri, 31 Oct 2025 08:41:46 GMT

Xenetic Biosciences, Inc
(NASDAQ:XBIO) 

XBIO stock logo

Xenetic Biosciences, Inc., a biopharmaceutical company, focuses on advancing XCART, a personalized chimeric antigen receptor T cell (CAR T) platform technology engineered to target patient-specific tumor neoantigens. The company engages in the development of biologic drugs and oncology therapeutics....

Founded: 1997
Full Time Employees: 4
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends